Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Subclinical cardiovascular disease and polycystic ovary syndrome
Joanne Michelle D. Gomez, Katherine VanHise, Nina S. Stachenfeld, et al.
Fertility and Sterility (2022) Vol. 117, Iss. 5, pp. 912-923
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Screening of serum biomarkers in patients with PCOS through lipid omics and ensemble machine learning
Jiying Chen, W. Chen, Zhiying Zhu, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313494-e0313494
Open Access | Times Cited: 1
Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)—Searching for Epigenetic Factors
Dariusz Szukiewicz, Seweryn Trojanowski, Anna Kociszewska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14663-14663
Open Access | Times Cited: 40
Polycystic Ovary Syndrome Fuels Cardiovascular Inflammation and Aggravates Ischemic Cardiac Injury
Ling Gao, Yichao Zhao, Haiyan Wu, et al.
Circulation (2023) Vol. 148, Iss. 24, pp. 1958-1973
Open Access | Times Cited: 28
The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review
Jenan Sh. Nasser, Noor Altahoo, Sayed Husain Almosawi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 903-903
Open Access | Times Cited: 12
Risk of cardiocerebrovascular diseases is increased in Korean women with polycystic ovary syndrome: a nationwide cohort study
Ki-Jin Ryu, Hyuntae Park, Min Sun Kim, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
The relationship between polycystic ovary syndrome and insulin resistance from 1983 to 2022: A bibliometric analysis
Tong Chen, Yue Yu, Jia Fan, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 24
Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy
Maëliss Peigné, Virginie Simon, Pascal Pigny, et al.
Human Reproduction (2023) Vol. 38, Iss. 5, pp. 938-950
Open Access | Times Cited: 13
The relationship between polycystic ovary syndrome and coronary heart disease: a bibliometric analysis
Xuzhi Liang, Haijing He, Hao Zeng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
Long-term exposure to reduced specific-size ambient particulate matter and progression of arterial stiffness among Chinese adults
Dankang Li, Shouling Wu, Linxi Tang, et al.
Journal of Hazardous Materials (2024) Vol. 466, pp. 133482-133482
Closed Access | Times Cited: 4
2023 International Evidence‐Based Polycystic Ovary Syndrome Guideline Update: Insights From a Systematic Review and Meta‐Analysis on Elevated Clinical Cardiovascular Disease in Polycystic Ovary Syndrome
Chau Thien Tay, Aya Mousa, Aadhya Vyas, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 4
Polycystic ovary syndrome (PCOS): progress towards a better understanding and treatment of the syndrome
Nour El Houda Mimouni, Paolo Giacobini
Comptes Rendus Biologies (2024) Vol. 347, Iss. G1, pp. 19-25
Open Access | Times Cited: 3
Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
Angelica Lindén Hirschberg
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 5, pp. 1202-1213
Open Access | Times Cited: 9
Bushenhuoluo Decoction improves polycystic ovary syndrome by regulating exosomal miR-30a-5p/ SOCS3/mTOR/NLRP3 signaling-mediated autophagy and pyroptosis
Qun Huang, Yuanbin Li, Zhuang Chen, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Polycystic ovary syndrome: A review of diagnosis and management, with special focus on atherosclerotic cardiovascular disease prevention
Merle Myerson, Rodis Paparodis, Robert Block, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 4, pp. e488-e500
Closed Access | Times Cited: 2
European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 Questionnaire
Sarantis Livadas, Bülent Okan Yıldız, George Mastorakos, et al.
European Journal of Endocrinology (2024) Vol. 191, Iss. 2, pp. 134-143
Closed Access | Times Cited: 2
Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome
Hongxia Deng, Yan Chen, Jiadi Xing, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Glycated Hemoglobin and Cardiovascular Disease in Patients Without Diabetes
Grzegorz K. Jakubiak, Artur Chwalba, Aleksandra Basek, et al.
Journal of Clinical Medicine (2024) Vol. 14, Iss. 1, pp. 53-53
Open Access | Times Cited: 2
Blood nesfatin-1 levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis
Mei Wang, Tong Jiao, Qing Zhu, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 1
Effects of menstrual disorders and dysmenorrhea on cardiovascular disease: a Mendelian randomization study
Sijia Lai, Qiubai Jin, Dayang Wang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
Chandrani Dutta, Spandana Maddukuri
Cureus (2024)
Open Access | Times Cited: 1
Nonobese young females with PCOS are at high risk for long-term cardiovascular disease
Xingping Zhao, Jie Wang, Dan Sun, et al.
European Journal of Preventive Cardiology (2024)
Closed Access | Times Cited: 1
Polycystic ovary syndrome as a metabolic disease
Nafiye Helvacı, Bülent Okan Yıldız
Nature Reviews Endocrinology (2024)
Closed Access | Times Cited: 1
Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1
Stephanie E. Areloegbe, Kehinde S. Olaniyi
Biochemical and Biophysical Research Communications (2023) Vol. 681, pp. 62-72
Closed Access | Times Cited: 2
Polycystic ovary syndrome and cardiovascular risk profile
Sophia-Marie Bohlen, Ludwig Kiesel
Gynäkologische Endokrinologie (2024) Vol. 22, Iss. 3, pp. 216-220
Closed Access
Butyrate alleviates adipose mitochondrial dysfunction and inflammation in experimental model of polycystic ovarian syndrome by modulating SIRT1-dependent mechanism
Kehinde S. Olaniyi, Stephanie E. Areloegbe
Nutrire (2024) Vol. 49, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top